Product image of Zejula (Niraparib Tosilate Monohydrate) supplied by GNH India

Zejula

Active Ingredient:
Niraparib Tosilate Monohydrate
Origin:
EU

Zejula (Niraparib Tosilate Monohydrate)

Zejula (niraparib tosylate monohydrate) is an oral prescription medication used in cancer care. It belongs to a class of drugs known as PARP inhibitors. This product is manufactured in the EU and intended for oral administration.

Manufacturer / TM Owner

Glaxosmithkline (Ireland) Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Zejula is used in the maintenance treatment of certain types of ovarian, fallopian tube, or primary peritoneal cancer. It may be prescribed after a patient has responded to platinum-based chemotherapy. The medication works by helping to prevent cancer cells from repairing their DNA, which can slow the growth of tumors. Patients often ask, 'what is niraparib used for' or 'niraparib tosylate monohydrate uses' when considering treatment options.

Side Effects

  • As a PARP inhibitor, niraparib tosylate monohydrate may help stabilize disease or slow progression in eligible patients. Common effects include gastrointestinal changes such as nausea or digestive discomfort. Some individuals may experience fatigue or changes in blood cell counts, which are monitored during treatment.

Precautions & Warnings

  • Zejula should be taken exactly as prescribed by a healthcare provider. It is important to attend all scheduled blood tests and follow-up appointments to monitor for potential side effects. Patients should inform their doctor about any other medications or supplements they are taking before starting this treatment.

Avoid Interactions

  • Niraparib tosylate monohydrate may interact with other drugs, including certain antidepressants, antifungals, and blood thinners. Combining it with strong CYP3A inhibitors or inducers can affect how the medication works. Alcohol use should be discussed with a healthcare provider, as it may influence treatment tolerance.

Frequently Asked Questions

It is used in the maintenance treatment of certain ovarian, fallopian tube, or primary peritoneal cancers after platinum-based chemotherapy.

Zejula is taken orally as prescribed by a healthcare provider, typically once daily with or without food.

Common side effects may include nausea, fatigue, or changes in blood cell counts, which are monitored during treatment.

Other medications should be reviewed by a healthcare provider, as some may interact with niraparib tosylate monohydrate.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Niraparib Tosilate Monohydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT